A study in AD mouse models used fluorescence microscopy to show that increased VEGF-A signaling resulted in decreased cerebral blood flow, indicating that this phenomenon may be a result of impaired VEGF signaling in AD patients [78]. This evidence concerns the gene VEGFA and Alzheimer disease.